Incident vertebral fractures in children with leukemia during the four years following diagnosis

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 9, 2015, Pages 3408-3417

  Cummings, Elizabeth A ^a   Ma, Jinhui ^b   Fernandez, Conrad V ^a   Halton, Jacqueline ^b   Alos, Nathalie ^c   Miettunen, Paivi M ^d   Jaremko, Jacob L ^e   Ho, Josephine ^d   Shenouda, Nazih ^b   Matzinger, Mary Ann ^b   Lentle, Brian ^f   Stephure, David ^d   Stein, Robert ^g   Sbrocchi, Ann Marie ^h   Rodd, Celia ⁱ   Lang, Bianca ^a   Israels, Sara ⁱ   Grant, Ronald M ^j   Couch, Robert ^e   Barr, Ronald ^k   Hay, John ^l   Rauch, Frank ^h   Siminoski, Kerry ^e   Ward, Leanne M ^b   more..

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

^h MCGILL UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF MANITOBA   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k MCMASTER UNIVERSITY   (Canada)

^l BROCK UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ARTICLE; BONE DENSITY; CANCER HORMONE THERAPY; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE INTENSIFICATION; DRUG EXPOSURE; FEMALE; HUMAN; INCIDENCE; INCIDENTAL FINDING; LUMBAR SPINE BONE MINERAL DENSITY; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PUBERTY; RISK ASSESSMENT; SPINE FRACTURE; SPINE RADIOGRAPHY; SYSTEMIC THERAPY; TREATMENT DURATION; LONGITUDINAL STUDY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; SPINAL FRACTURES;

ANTINEOPLASTIC AGENTS; BONE DENSITY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SPINAL FRACTURES;

EID: 84941703072     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/JC.2015-2176     Document Type: Article

References (40)

1. Pui CH, Evans WE. A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol. 2013;50:185-196.
2. Baty JM, Vogt EC. Bone changes of leukemia in children. AJR Am J Roentgenol. 1935;34:310-313.
3. Clark JJ. Unusual bone changes in leukemia. Radiology. 1936;26: 237-242.
4. Clausen N, Gøtze H, Pedersen A, Riis-Petersen J, Tjalve E. Skeletal scintigraphy and radiography at onset of acute lymphocytic leukemia in children. Med Pediatr Oncol. 1983;11:291-296.
5. Halton J, Gaboury I, Grant R, et al. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res 2009;24:1326-1334.
6. Alos N, Grant RM, Ramsay T, et al. High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clin Oncol. 2012;30:2760-2767.
7. van der Sluis IM, van den Heuvel-EibrinkMM,Hählen K, Krenning EP, de Muinck Keizer-Schrama SM. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr. 2002;141:204-210.
8. Riccio I, Marcarelli M, Del Regno N, et al. Musculoskeletal problems in pediatric acute leukemia. J Pediatr Orthop B. 2013;22:264-269.
9. Willson JK. The bone lesions of childhood leukemia; a survey of 140 cases. Radiology. 1959;72:672-681.
10. Simmons CR, Harle TS, Singleton EB. The osseous manifestations of leukemia in children. Radiol Clin North Am. 1968;6:115-130.
11. Rogalsky RJ, Black GB, Reed MH. Orthopaedic manifestations of leukemia in children. J Bone Joint Surg 1986;68-A:494-501.
12. Silverman FN. The skeletal lesions in leukemia; clinical and roentgenographic observations in 103 infants and children, with a review of the literature.AmJ RoentgenolRadiumTher. 1948;59:819-844.
13. Halton JM, Atkinson SA, Fraher L, et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr. 1995;126:557-564.
14. Atkinson SA, Fraher L, Gundberg CM, Andrew M, Pai M, Barr RD. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr. 1989;114:793-800.
15. Jayanthan A, Miettunen PM, Incoronato A, et al. Childhood acute lymphoblastic leukemia (ALL) presenting with severe osteolysis: a model to study leukemia-bone interactions and potential targeted therapeutics. Pediatr Hematol Oncol. 2010;27:212-227.
16. MarshallWA,Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291-303.
17. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13-23.
18. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109:45-60.
19. WHO Multicentre Growth Reference Study Group. The WHO Child Growth Standards: Length/Height-for-Age, Weight-for-Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age: Methods and Development. Geneva, Switzerland: World Health Organization; 2006:229-300.
20. Pritchard JM, Seechurn T, Atkinson SA. A food frequency questionnaire for the assessment of calcium, Vitamin D and vitamin K: a pilot validation study. Nutrients. 2010;2:805-819.
21. Institute of Medicine. Dietary Reference Intakes for Calcium and VitaminD. Washington, DC: The National Academies Press; 2011.
22. Huber AM, Gaboury I, Cabral DA, et al. Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken). 2010; 62:516-526.
23. Hay J. Development and validation of the Habitual Activity Estimation Scale (HAES). In Children and Exercise XIX: Promoting Health and Well-Being London, UK; E&FN Spon, 1997:125-129.
24. Curtis JR, WestfallAO,Allison J, et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 2006;55:420-426.
25. Dubner SE, Shults J, Baldassano RN, et al. Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology. 2009;136:123-130.
26. van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002;13:777-787.
27. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8:1137-1148.
28. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. 2nd ed. Stanford, CA: Stanford University Press; 1959.
29. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York, NY: Springer-Verlag; 2000.
30. Abrahamowicz M, MacKenzie T, Esdaile JM. Time-dependent hazard ratio: modeling and hypothesis testing with application in lupus nephritis. J Am Stat Assoc. 1996;91:1432-1439.
31. Högler W, Wehl G, van Staa T, Meister B, Klein-Franke A, Kropshofer G. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database. Pediatr Blood Cancer. 2007;48:21-27.
32. te Winkel ML, Pieters R, Hop WC, et al. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol. Bone. 2014;59:223-228.
33. Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoidinduced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18:1319-1328.
34. Rayar MS, Nayiager T, Webber CE, Barr RD, Athale UH. Predictors of bony morbidity in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2012;59:77-82.
35. Rodd C, Lang B, Ramsay T, et al. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res (Hoboken). 2012;64:122-131.
36. Marinovic D, Dorgeret S, Lescoeur B, et al. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study. Pediatrics. 2005;116:e102-108.
37. Gurney JG, Kaste SC, Liu W, et al. Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer. 2014;61:1270-1276.
38. Mostoufi-Moab S, Brodsky J, Isaacoff EJ, et al. Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation. J Clin Endocrinol Metab. 2012;97:3584-3592.
39. Ma J, Siminoski K, Alos N, Halton J, et al. The choice of normative pediatric reference database changes spine bone mineral density Zscores but not the relationship between bone mineral density and prevalent vertebral fractures. J Clin Endocrinol Metab. 2015;100: 1018-1027.
40. Kaste SC, Qi A, Smith K, et al. Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer. 2014;61:885-893.